Get the Stockscreener App
1.49
3.87%
-0.06
60 Degrees Pharmaceuticals Inc stock is traded at $1.49, with a volume of 33,072.
It is down -3.87% in the last 24 hours and down -49.66% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$1.55
Open:
$1.49
24h Volume:
33,072
Relative Volume:
0.01
Market Cap:
$3.68M
Revenue:
$1.35M
Net Income/Loss:
$-7.97M
P/E Ratio:
-0.0606
EPS:
-24.6063
Net Cash Flow:
$-6.88M
1W Performance:
-22.80%
1M Performance:
-49.66%
6M Performance:
-72.61%
1Y Performance:
-80.19%
1-Day Range:
$1.47
$1.55
1-Week Range:
$1.29
$1.98
52-Week Range:
$1.29
$17.68
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.49 | 3.83M | 1.35M | -7.97M | -6.88M | -24.61 |
VRTX
Vertex Pharmaceuticals Inc
|
451.39 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.55 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
329.82 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
687.64 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.26 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
Published on: 2026-03-26 13:08:49 - baoquankhu1.vn
Gap Down: Is 60 Degrees Pharmaceuticals Inc Equity Warrant part of any major index2026 Geopolitical Influence & Verified Trade Idea Suggestions - baoquankhu1.vn
Signal Recap: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising rates2026 Price Momentum & AI Powered Market Trend Analysis - baoquankhu1.vn
If You Invested $1,000 in 60 degrees pharmaceuticals, Inc. (SXTP) - Stock Titan
Performance Recap: Is 60 Degrees Pharmaceuticals Inc a momentum stock2026 Buyback Activity & Reliable Price Action Trade Plans - baoquankhu1.vn
60 Degrees Updates Affiliate Share Ownership Disclosure Error - The Globe and Mail
Aug Levels: Can 60 Degrees Pharmaceuticals Inc continue delivering strong returns - baoquankhu1.vn
60 Degrees Pharmaceuticals, Inc. Corrects Prospectus Supplement Disclosure in SEC Form 8-K Filing (March 20, 2026) - Minichart
60 Degrees Pharmaceuticals corrects affiliate share counts in prospectus supplement - TradingView
Affiliate share ownership restated by 60 Degrees (NASDAQ: SXTP) - Stock Titan
Death Cross: Is 60 Degrees Pharmaceuticals Inc Equity Warrant a top pick in the sector2026 Key Highlights & AI Powered Market Entry Ideas - baoquankhu1.vn
60 Degrees Pharma submits dietary supplement notification to FDA By Investing.com - Investing.com Australia
Bull Run: Can 60 Degrees Pharmaceuticals Inc sustain earnings growth2026 Trade Ideas & Safe Swing Trade Setups - baoquankhu1.vn
60 Degrees submits NDIN to FDA for Australian Chestnut Extract - TipRanks
60 Degrees Pharma submits dietary supplement notification to FDA - Investing.com
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract - TradingView
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract - The Manila Times
Gains Report: Can 60 Degrees Pharmaceuticals Inc be recession proofInsider Buying & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Market Review: Is 60 Degrees Pharmaceuticals Inc Equity Warrant a top pick in the sectorMarket Growth Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Volatility Watch: Whats the fair value of 60 Degrees Pharmaceuticals Inc stock2026 Valuation Update & Weekly Breakout Stock Alerts - baoquankhu1.vn
60 Degrees Pharmaceuticals files updated legal opinion for at-the-market offering - Investing.com Nigeria
What's going on with 60 Degrees Pharmaceuticals on Friday? - MSN
60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), BioLife Solutions (BLFS) - The Globe and Mail
60 Degrees Pharmaceuticals, Inc. Files Updated Legal Opinion for ATM Equity Offering Program – March 2026 - Minichart
60 Degrees Pharmaceuticals files updated legal opinion for ATM equity program - Investing.com Australia
60 Degrees Pharmaceuticals files updated legal opinion confirming ATM program share validity - TradingView
60 Degrees Pharmaceuticals Updates Opinion for ATM Program - The Globe and Mail
60 Degrees (SXTP) updates ATM capacity to $565K after prior sales - Stock Titan
60 Degrees Pharmaceuticals (SXTP) updates legal opinion for at-the-market stock program - Stock Titan
What's Going On With 60 Degrees Pharmaceuticals On Friday? - Benzinga
Quarterly Risk: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising ratesPortfolio Gains Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn
60 Degrees Pharmaceuticals, Inc. Files Form 8-K With NASDAQ Listing Details and Corporate Information - Minichart
60 Degrees Pharmaceuticals (NASDAQ: SXTP) updates legal opinion for ATM equity program - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
60 Degrees Pharma flies after curing tick disease in small-scale study - Mugglehead Investment Magazine
60 Degrees reports babesiosis cure in three trial patients - Investing.com India
60 Degrees reports babesiosis cure in three trial patients By Investing.com - Investing.com Canada
[424B5] 60 DEGREES PHARMACEUTICALS, INC. Prospectus Supplement (Debt Securities) - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
SXTP Stock Dips Amid Earnings Shake: Investors On Edge - timothysykes.com
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial - The Manila Times
60 Degrees Pharmaceuticals Announces All Patients Cured of - GlobeNewswire
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Panama City News Herald
Big Picture: What are analysts price targets for 60 Degrees Pharmaceuticals Inc Equity WarrantJuly 2025 Snapshot & Long-Term Capital Growth Ideas - baoquankhu1.vn
How interest rate cuts could boost 60 Degrees Pharmaceuticals Inc. stockTake Profit & AI Enhanced Execution Alerts - Naître et grandir
Earnings Update: Whats the fair value of 60 Degrees Pharmaceuticals Inc stock2025 Sector Review & Risk Managed Investment Strategies - baoquankhu1.vn
Top 2seventy bio (ZTWO) Competitors 2026 - MarketBeat
Short Squeeze: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising rates2025 Geopolitical Influence & AI Forecasted Stock Moves - baoquankhu1.vn
SXTP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SXTPW SEC Filings60 Degrees Pharm 10-K, 10-Q, 8-K Forms - Stock Titan
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
| XU CHERYL | Director |
Jun 03 '25 |
Buy |
2.88 |
5,000 |
14,410 |
15,816 |
0.99%
3.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):